129 related articles for article (PubMed ID: 17074113)
1. [The clinical outcome and immune reconstitution in 45 advanced AIDS patients undergoing highly active antiretroviral therapy for 12 months].
Ruan GR; Qiu ZF; Li TS; Han Y; Xie J; Zuo LY; Ma XJ; Liu ZY; Wang AX
Zhonghua Nei Ke Za Zhi; 2006 Jul; 45(7):569-72. PubMed ID: 17074113
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.
Dai Y; Qiu ZF; Li TS; Han Y; Zuo LY; Xie J; Ma XJ; Liu ZY; Wang AX
Chin Med J (Engl); 2006 Oct; 119(20):1677-82. PubMed ID: 17097013
[TBL] [Abstract][Full Text] [Related]
3. [The evaluation of four-year highly active antiretroviral therapy in HIV-1 infected patients].
Deng XJ; He Y; Yang L; Zou SP; Yang H; Zheng YH
Zhonghua Nei Ke Za Zhi; 2011 Mar; 50(3):230-4. PubMed ID: 21600088
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
5. [The therapeutic effects of highly active anti-retroviral therapy in 74 treatment-naive patients with AIDS in China].
Chen XJ; Tang XP; Cai WP; Zhang JS; Chen JF; Liu QC; Zhong HL; He HL; Li LH; Zhao B; Shang H
Zhonghua Nei Ke Za Zhi; 2011 Jan; 50(1):59-62. PubMed ID: 21418892
[TBL] [Abstract][Full Text] [Related]
6. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
[TBL] [Abstract][Full Text] [Related]
7. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
8. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
9. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
10. [Cellular HIV DNA quantitative testing and its significance in Chinese AIDS patients during 48 weeks' highly-active antiretroviral treatment].
Zheng YH; Alius DM; Chen X; He Y; He B; He M; Wang HY; Xiao SL; Luo Y; Yao YH; Lin YH; Chen Z; Zhou HY
Zhonghua Nei Ke Za Zhi; 2012 Sep; 51(9):708-12. PubMed ID: 23158922
[TBL] [Abstract][Full Text] [Related]
11. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS
Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757
[TBL] [Abstract][Full Text] [Related]
12. T-cell response of advanced aids patients after highly active antiretroviral therapy.
Wang AX; Li TS; Cao YZ; Han Y; Qiu ZF; Xie J
Chin Med Sci J; 2005 Dec; 20(4):223-5. PubMed ID: 16422247
[TBL] [Abstract][Full Text] [Related]
13. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics of highly active antiretroviral therapy-associated immune reconstruction inflammation in acquired immunodeficiency syndrome].
Liu M; Zheng YH; Zhou GQ; Zhou HY; Chen Z; He Y; Chen X; Zheng LW; Jia L; He M
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):304-8. PubMed ID: 21419003
[TBL] [Abstract][Full Text] [Related]
15. [Intervention of immune 1 combined HAART on immune function in patients with HIV/AIDS reconstruction].
Wu XF; Wang J; Li Y
Zhongguo Zhong Yao Za Zhi; 2013 Aug; 38(15):2453-7. PubMed ID: 24228534
[TBL] [Abstract][Full Text] [Related]
16. Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART.
Taiwo BO; Li X; Palella F; Jacobson LP; Margolick JB; Detels R; Rinaldo CR; Phair JP
HIV Med; 2009 Nov; 10(10):657-60. PubMed ID: 19601997
[TBL] [Abstract][Full Text] [Related]
17. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
[TBL] [Abstract][Full Text] [Related]
18. [Follow-up study on 84 AIDS patients having received the replaced therapy program for six months in one county of Henan, China].
Liu J; Cui WG; Xue XJ; Sun GQ; Tian SA; Liu CH; Cheng YW; Wang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Sep; 33(9):893-7. PubMed ID: 23290797
[TBL] [Abstract][Full Text] [Related]
19. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S
Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
[TBL] [Abstract][Full Text] [Related]
20. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
